Drug
Anvumetostat
Anvumetostat: highest development phase Phase 1, developed by Amgen. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Amgen
Trials
| Drug | Phase | Indication |
|---|---|---|
| Anvumetostat NCT06333951 | Phase 1 | Thoracic Tumors |
Latest
No recent events.
Follow Anvumetostat on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.